research Reversible Hair Loss in Lichen Planopilaris: Regrowth With Low-Dose Naltrexone and Platelet-Rich Plasma
Low-dose naltrexone and platelet-rich plasma can regrow hair in lichen planopilaris.
Search
for
Sort by
Research
300-330 / 1000+ results
research Chronic Telogen Effluvium
Chronic Telogen Effluvium is a hair loss condition in middle-aged women that usually doesn't lead to complete baldness.
research Expert Opinion on Current and Emerging Treatment Options in Androgenetic Alopecia and Telogen Effluvium: An Indian Perspective
Early diagnosis and personalized treatment are crucial for managing hair loss in India.
research Topical Finasteride for Male and Female Pattern Hair Loss: Is It a Safe and Effective Alternative?
Topical finasteride is a safe and effective treatment for pattern hair loss with fewer side effects than oral finasteride.
research Treatment Options for Androgenetic Alopecia: Efficacy, Side Effects, Compliance, Financial Considerations, and Ethics
Combination therapies for androgenetic alopecia work best but can have significant side effects and costs.
research Clinical Approach to Focal Hairless Patch with Dermoscopy
Dermoscopy helps diagnose different hair loss conditions, and characteristics vary among ethnicities and individual cases.
research Congenital Triangular Alopecia: A Case Report
Congenital triangular alopecia is a hair loss condition present from birth or early childhood with no effective treatment needed.
research The Effect of Topical Minoxidil in the Treatment of Androgenetic Alopecia
Minoxidil effectively treats hair loss in both men and women.
research The Nominal Trial: Clinical Efficacy, Cosmetic Acceptability, and Local Tolerability of Topical 5% Minoxidil Lotion Without Propylene Glycol: A 6-Month, Multicentre, Real-Life, Prospective, Assessor-Blinded Study in 196 Subjects With Hair Loss
The 5% minoxidil lotion without propylene glycol is effective, well-tolerated, and cosmetically acceptable for hair loss.
research Update Treatment of Male Androgenetic Alopecia
The best treatment for male pattern baldness is a combination of topical minoxidil and oral finasteride.
research Comparative Efficacy of Transdermal Forms for Alopecia Therapy
The gel form of substance Y is the most effective for treating hair loss.
research Clinical Utility and Validity of Minoxidil Response Testing in Androgenetic Alopecia
A hair test can accurately predict if a person with hair loss will respond to minoxidil treatment.
research Guidelines for the Diagnosis and Treatment of Male-Pattern and Female-Pattern Hair Loss, 2017 Version
Use finasteride, dutasteride, and minoxidil for hair loss treatment.
research Three Percent Topical Minoxidil Therapy for Female Androgenetic Alopecia
Using 3% topical minoxidil can help women with hair loss, but more research is needed.
research Permanent Alopecia in Patients with Breast Cancer After Taxane Chemotherapy and Adjuvant Hormonal Therapy: Clinicopathologic Findings in a Cohort of 10 Patients
Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.
research Vehicle-Dependent Allergic Contact Dermatitis Due to Topical Minoxidil Solution
Patch testing with different solvents helps find the right minoxidil formulation for those with scalp allergies.
research Comparative Efficacy of Various Treatment Regimens for Androgenetic Alopecia in Men
Best hair growth results from combining finasteride and minoxidil.
research Hair Diseases: Alopecia Areata and Androgenetic Alopecia
Alopecia areata, a type of hair loss, may be passed through T cells and has genetic links, while treatments vary in effectiveness. Male pattern baldness can be treated with finasteride and is influenced by androgens in hair follicles.
research Hair Loss After Drug Reaction With Eosinophilia and Systemic Symptoms: A Multicentric Retrospective Case Series
Some types of hair loss can continue for a long time after recovering from a severe drug reaction known as DRESS.
research Male Androgenetic Alopecia
Hair loss in men treated best with early medication or transplant, new treatments researched.
research Coexistence of Woolly Hair and Monilethrix: A Case Study
Two sisters have rare hair disorders causing short, fragile, kinky hair.
research Comparison of Treatment with Oral Vitamin D Alone, Topical Minoxidil, or Combination in Female Pattern Hair Loss
Combining oral vitamin D with topical minoxidil is most effective for improving female pattern hair loss.
research An Overview of Management of Drug-Induced Hair and Nail Disorders
Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.
research The Chinese State Food and Drug Administration Has Issued Sinovac Biotech a New Drug Certificate Approving Its Split Influenza Vaccine
China approved Sinovac's flu vaccine, Japan approved RiUP for female hair loss, and Nippon Kayaku's three cancer drugs.
research Efficacy of Topical Minoxidil and Finasteride Combination Versus Monotherapy in Men With Androgenetic Alopecia: A Prospective, Randomized, Controlled, Assessor-Blinded, 3-Arm, Pilot Trial
Using both minoxidil and finasteride together on the scalp works better for male hair loss than using either one alone.
research Hair-Raising Costs: Evaluating Botulinum Toxin Treatment for Androgenetic Alopecia
Botulinum toxin is not effective or cost-efficient for treating male pattern baldness.
research Minoxidil: Mechanisms of Action on Hair Growth
Minoxidil boosts hair growth by opening potassium channels and increasing cell activity.
research Hair Follicle Miniaturization in a Woolly Hair Nevus
The boy with woolly hair nevus had thinner hair and abnormal hair follicles, which improved with treatment but worsened when treatment stopped.
research Medical Management of Male Pattern Hair Loss
Minoxidil and finasteride can slow or halt hair loss, but may have side effects.
research Treatment of Post-COVID-19 Telogen Effluvium
Topical Minoxidil is effective for hair loss after COVID-19.